ImmuneID Announces Close of $50 Million Series A Financing
Longwood Fund-founded company has raised over $70 million since its Q4 2020 launch Proprietary platform licensed from Dr. Stephen Elledge’s laboratory used to develop novel...
Category : Clinical Intelligence/Clinical Efficiency
BEKHealth Secures $4M for AI Clinical Research Software Platform
Support from a consortium of leading healthcare investors and Change Healthcare will enable the company to grow platform to streamline and automate clinical research processes...
OncoNano Medicine Raises ~$50 Million
Financing round led by Advantech healthcare investment team Funds will support Phase 3 program for pegsitacianine and IND-enabling activities for ONM-501 OncoNano Medicine, Inc. today announced...
Apollo Therapeutics Completes $145 Million Financing
Proceeds to support rapid advancement of pipeline with over 15 therapeutic programs currently in development across oncology, major inflammatory disorders and rare disease Company to...
Umoja Biopharma Closes an Oversubscribed $210 Million Series B
Series B financing co-led by SoftBank Vision Fund 2 and Cormorant Asset Management Financing accelerates development of Umoja’s pipeline of in vivo engineered CAR T...
RNA Medicines Developer Ochre Bio Closes $9.6M Seed Financing
Funding will be used to develop RNA therapies for transplant and chronic liver diseases Ochre Bio has built a deep phenotyping platform to identify novel...
Novel Drug Binders Developer RayzeBio Secures $108 Million
–Total raise of $258 million since company launch in August 2020– RayzeBio, Inc., which is discovering and developing a broad pipeline of innovative targeted radiopharmaceutical...
Alentis Therapeutics Raises USD 67 Million in Series B
Funding to Advance Pipeline of Anti-fibrotic Molecules into the Clinic Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, today announced that it...
TransPerfect Life Sciences Unveils AI-Powered TMF Automation
TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced its...
HiFiBiO Therapeutics Closes $75 Million Series D Financing
Latest funding led by Mirae Asset Financial Group and joined by B Capital Group, Sherpa, and other new investors together with existing investors such as...